A Study of BBI503 in Adult Patients With Advanced Solid Tumors

Clinical trial NCT01781455 · COMPLETED

Trial details

NCT number: NCT01781455
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer, Advanced Solid Tumors

Start date: 2012-02-01
Primary completion: 2020-06-01
Enrollment: 311

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.